CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 16 enrolled
Drug / intervention
Clomiphene Citratedrug
Likely dose
Clomiphene Citrate 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02274311
NCT02274311Phase 2Completed
CompareCT.gov

Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies

Felipe Henning Gaia Duarte·interventional·Posted Oct 24, 2014·Updated May 7, 2019

In Brief

A Phase 2 clinical trial evaluating Clomiphene Citrate for Acromegaly. Completed, enrolled 16 participants.

Detailed Summary

To assess the impact of clomiphene citrate on serum insulin like growth factor 1 and testosterone levels in male acromegalic patients not controlled by surgery, radiotherapy and/or medical treatments (somatostatin analogues, dopamine agonists and/or growth hormone receptor antagonist)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcromegaly
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 24, 2014
Enrollment StartJan 1, 2011
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 11.7 years ago

Interventions

Clomiphene Citratedrug

Clomiphene citrate, 50 mg, orally for three months